Literature DB >> 35648366

Letter to the editor regarding Bartalena et al. 2022.

T J Smith1,2.   

Abstract

Entities:  

Year:  2022        PMID: 35648366     DOI: 10.1007/s40618-022-01828-0

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


× No keyword cloud information.
  1 in total

1.  Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity.

Authors:  L Bartalena; C Marcocci; M L Tanda; M Marinò
Journal:  J Endocrinol Invest       Date:  2022-05-28       Impact factor: 5.467

  1 in total
  1 in total

1.  Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity.

Authors:  L Bartalena; C Marcocci; M L Tanda; M Marinò
Journal:  J Endocrinol Invest       Date:  2022-05-28       Impact factor: 5.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.